><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="book"><collab>World Health Organization</collab>. <source>Global Tuberculosis Report 2013</source>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>WHO Press</publisher-name> (<year>2013</year>).</mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pai</surname><given-names>M</given-names></name></person-group>
<article-title>Spectrum of latent tuberculosis &#x02013; existing tests cannot resolve the underlying phenotypes</article-title>. <source>Nat Rev Microbiol</source> (<year>2010</year>) <volume>8</volume>(<issue>3</issue>):<fpage>242</fpage><pub-id pub-id-type="doi">10.1038/nrmicro2236-c1</pub-id><pub-id pub-id-type="pmid">20084059</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mack</surname><given-names>U</given-names></name><name><surname>Migliori</surname><given-names>GB</given-names></name><name><surname>Sester</surname><given-names>M</given-names></name><name><surname>Rieder</surname><given-names>HL</given-names></name><name><surname>Ehlers</surname><given-names>S</given-names></name><name><surname>Goletti</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>LTBI: latent tuberculosis infection or lasting immune responses to <italic>M. tuberculosis</italic>? A TBNET consensus statement</article-title>. <source>Eur Respir J</source> (<year>2009</year>) <volume>33</volume>(<issue>5</issue>):<fpage>956</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1183/09031936.00120908</pub-id><?supplied-pmid 19407047?><pub-id pub-id-type="pmid">19407047</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>DB</given-names></name><name><surname>Gideon</surname><given-names>HP</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name></person-group>. <article-title>Eliminating latent tuberculosis</article-title>. <source>Trends Microbiol</source> (<year>2009</year>) <volume>17</volume>(<issue>5</issue>):<fpage>183</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.tim.2009.02.005</pub-id><?supplied-pmid 19375916?><pub-id pub-id-type="pmid">19375916</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>P</given-names></name><name><surname>Doherty</surname><given-names>TM</given-names></name><name><surname>Pai</surname><given-names>M</given-names></name><name><surname>Weldingh</surname><given-names>K</given-names></name></person-group>. <article-title>The prognosis of latent tuberculosis: can disease be predicted?</article-title>
<source>Trends Mol Med</source> (<year>2007</year>) <volume>13</volume>(<issue>5</issue>):<fpage>175</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1016/j.molmed.2007.03.004</pub-id><?supplied-pmid 17418641?><pub-id pub-id-type="pmid">17418641</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mangtani</surname><given-names>P</given-names></name><name><surname>Abubakar</surname><given-names>I</given-names></name><name><surname>Ariti</surname><given-names>C</given-names></name><name><surname>Beynon</surname><given-names>R</given-names></name><name><surname>Pimpin</surname><given-names>L</given-names></name><name><surname>Fine</surname><given-names>PE</given-names></name><etal/></person-group>
<article-title>Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials</article-title>. <source>Clin Infect Dis</source> (<year>2014</year>) <volume>58</volume>(<issue>4</issue>):<fpage>470</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1093/cid/cit790</pub-id><?supplied-pmid 24336911?><pub-id pub-id-type="pmid">24336911</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colditz</surname><given-names>GA</given-names></name><name><surname>Brewer</surname><given-names>TF</given-names></name><name><surname>Berkey</surname><given-names>CS</given-names></name><name><surname>Wilson</surname><given-names>ME</given-names></name><name><surname>Burdick</surname><given-names>E</given-names></name><name><surname>Fineberg</surname><given-names>HV</given-names></name><etal/></person-group>
<article-title>Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature</article-title>. <source>JAMA</source> (<year>1994</year>) <volume>271</volume>(<issue>9</issue>):<fpage>698</fpage>&#x02013;<lpage>702</lpage>.<pub-id pub-id-type="doi">10.1001/jama.1994.03510330076038</pub-id><?supplied-pmid 8309034?><pub-id pub-id-type="pmid">8309034</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Day</surname><given-names>CL</given-names></name><name><surname>Tameris</surname><given-names>M</given-names></name><name><surname>Mansoor</surname><given-names>N</given-names></name><name><surname>van Rooyen</surname><given-names>M</given-names></name><name><surname>de Kock</surname><given-names>M</given-names></name><name><surname>Geldenhuys</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2013</year>) <volume>188</volume>(<issue>4</issue>):<fpage>492</fpage>&#x02013;<lpage>502</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.201208-1385OC</pub-id><?supplied-pmid 23306546?><pub-id pub-id-type="pmid">23306546</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillard</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>PC</given-names></name><name><surname>Danilovits</surname><given-names>M</given-names></name><name><surname>Su</surname><given-names>WJ</given-names></name><name><surname>Cheng</surname><given-names>SL</given-names></name><name><surname>Pehme</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Safety and immunogenicity of the M72/AS01<sub>E</sub> candidate tuberculosis vaccine in adults with tuberculosis: a phase II randomised study</article-title>. <source>Tuberculosis (Edinb)</source> (<year>2016</year>) <volume>100</volume>:<fpage>118</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="doi">10.1016/j.tube.2016.07.005</pub-id><?supplied-pmid 27553419?><pub-id pub-id-type="pmid">27553419</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leroux-Roels</surname><given-names>I</given-names></name><name><surname>Forgus</surname><given-names>S</given-names></name><name><surname>De Boever</surname><given-names>F</given-names></name><name><surname>Clement</surname><given-names>F</given-names></name><name><surname>Demoiti&#x000e9;</surname><given-names>MA</given-names></name><name><surname>Mettens</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Improved CD4<sup>+</sup> T cell responses to <italic>Mycobacterium tuberculosis</italic> in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: a randomized trial</article-title>. <source>Vaccine</source> (<year>2013</year>) <volume>31</volume>(<issue>17</issue>):<fpage>2196</fpage>&#x02013;<lpage>206</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2012.05.035</pub-id><pub-id pub-id-type="pmid">22643213</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montoya</surname><given-names>J</given-names></name><name><surname>Solon</surname><given-names>JA</given-names></name><name><surname>Cunanan</surname><given-names>SR</given-names></name><name><surname>Acosta</surname><given-names>L</given-names></name><name><surname>Bollaerts</surname><given-names>A</given-names></name><name><surname>Moris</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>A randomized, controlled dose-finding Phase II study of the M72/AS01 candidate tuberculosis vaccine in healthy PPD-positive adults</article-title>. <source>J Clin Immunol</source> (<year>2013</year>) <volume>33</volume>(<issue>8</issue>):<fpage>1360</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1007/s10875-013-9949-3</pub-id><?supplied-pmid 24142232?><pub-id pub-id-type="pmid">24142232</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penn-Nicholson</surname><given-names>A</given-names></name><name><surname>Geldenhuys</surname><given-names>H</given-names></name><name><surname>Burny</surname><given-names>W</given-names></name><name><surname>van der Most</surname><given-names>R</given-names></name><name><surname>Day</surname><given-names>CL</given-names></name><name><surname>Jongert</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Safety and immunogenicity of candidate vaccine M72/AS01<sub>E</sub> in adolescents in a TB endemic setting</article-title>. <source>Vaccine</source> (<year>2015</year>) <volume>33</volume>(<issue>32</issue>):<fpage>4025</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2015.05.088</pub-id><?supplied-pmid 26072017?><pub-id pub-id-type="pmid">26072017</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumarasamy</surname><given-names>N</given-names></name><name><surname>Poongulali</surname><given-names>S</given-names></name><name><surname>Bollaerts</surname><given-names>A</given-names></name><name><surname>Moris</surname><given-names>P</given-names></name><name><surname>Beulah</surname><given-names>FE</given-names></name><name><surname>Ayuk</surname><given-names>LN</given-names></name><etal/></person-group>
<article-title>A randomized, controlled safety, and immunogenicity trial of the M72/AS01 candidate tuberculosis vaccine in HIV-positive Indian adults</article-title>. <source>Medicine (Baltimore)</source> (<year>2016</year>) <volume>95</volume>(<issue>3</issue>):<fpage>e2459</fpage>.<pub-id pub-id-type="doi">10.1097/MD.0000000000002459</pub-id><?supplied-pmid 26817879?><pub-id pub-id-type="pmid">26817879</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Idoko</surname><given-names>OT</given-names></name><name><surname>Owolabi</surname><given-names>OA</given-names></name><name><surname>Owiafe</surname><given-names>PK</given-names></name><name><surname>Moris</surname><given-names>P</given-names></name><name><surname>Odutola</surname><given-names>A</given-names></name><name><surname>Bollaerts</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: an open-label randomized controlled trial</article-title>. <source>Tuberculosis (Edinb)</source> (<year>2014</year>) <volume>94</volume>(<issue>6</issue>):<fpage>564</fpage>&#x02013;<lpage>78</lpage>.<pub-id pub-id-type="doi">10.1016/j.tube.2014.07.001</pub-id><?supplied-pmid 25305000?><pub-id pub-id-type="pmid">25305000</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thacher</surname><given-names>EG</given-names></name><name><surname>Cavassini</surname><given-names>M</given-names></name><name><surname>Audran</surname><given-names>R</given-names></name><name><surname>Thierry</surname><given-names>AC</given-names></name><name><surname>Bollaerts</surname><given-names>A</given-names></name><name><surname>Cohen</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy: a phase I/II, randomized trial</article-title>. <source>AIDS</source> (<year>2014</year>) <volume>28</volume>(<issue>12</issue>):<fpage>1769</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1097/QAD.0000000000000343</pub-id><?supplied-pmid 24911353?><pub-id pub-id-type="pmid">24911353</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torrado</surname><given-names>E</given-names></name><name><surname>Cooper</surname><given-names>AM</given-names></name></person-group>. <article-title>Cytokines in the balance of protection and pathology during mycobacterial infections</article-title>. <source>Adv Exp Med Biol</source> (<year>2013</year>) <volume>783</volume>:<fpage>121</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1007/978-1-4614-6111-1_7</pub-id><?supplied-pmid 23468107?><pub-id pub-id-type="pmid">23468107</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunes-Alves</surname><given-names>C</given-names></name><name><surname>Booty</surname><given-names>MG</given-names></name><name><surname>Carpenter</surname><given-names>SM</given-names></name><name><surname>Jayaraman</surname><given-names>P</given-names></name><name><surname>Rothchild</surname><given-names>AC</given-names></name><name><surname>Behar</surname><given-names>SM</given-names></name></person-group>. <article-title>In search of a new paradigm for protective immunity to TB</article-title>. <source>Nat Rev Microbiol</source> (<year>2014</year>) <volume>12</volume>(<issue>4</issue>):<fpage>289</fpage>&#x02013;<lpage>99</lpage>.<pub-id pub-id-type="doi">10.1038/nrmicro3230</pub-id><?supplied-pmid 24590243?><pub-id pub-id-type="pmid">24590243</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kagina</surname><given-names>BM</given-names></name><name><surname>Abel</surname><given-names>B</given-names></name><name><surname>Scriba</surname><given-names>TJ</given-names></name><name><surname>Hughes</surname><given-names>EJ</given-names></name><name><surname>Keyser</surname><given-names>A</given-names></name><name><surname>Soares</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2010</year>) <volume>182</volume>(<issue>8</issue>):<fpage>1073</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.201003-0334OC</pub-id><pub-id pub-id-type="pmid">20558627</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mittr&#x000fc;cker</surname><given-names>HW</given-names></name><name><surname>Steinhoff</surname><given-names>U</given-names></name><name><surname>Kohler</surname><given-names>A</given-names></name><name><surname>Krause</surname><given-names>M</given-names></name><name><surname>Lazar</surname><given-names>D</given-names></name><name><surname>Mex</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2007</year>) <volume>104</volume>(<issue>30</issue>):<fpage>12434</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0703510104</pub-id><?supplied-pmid 17640915?><pub-id pub-id-type="pmid">17640915</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majlessi</surname><given-names>L</given-names></name><name><surname>Simsova</surname><given-names>M</given-names></name><name><surname>Jarvis</surname><given-names>Z</given-names></name><name><surname>Brodin</surname><given-names>P</given-names></name><name><surname>Rojas</surname><given-names>MJ</given-names></name><name><surname>Bauche</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis</article-title>. <source>Infect Immun</source> (<year>2006</year>) <volume>74</volume>(<issue>4</issue>):<fpage>2128</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.74.4.2128-2137.2006</pub-id><?supplied-pmid 16552042?><pub-id pub-id-type="pmid">16552042</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derrick</surname><given-names>SC</given-names></name><name><surname>Yabe</surname><given-names>IM</given-names></name><name><surname>Yang</surname><given-names>A</given-names></name><name><surname>Morris</surname><given-names>SL</given-names></name></person-group>. <article-title>Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells</article-title>. <source>Vaccine</source> (<year>2011</year>) <volume>29</volume>(<issue>16</issue>):<fpage>2902</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2011.02.010</pub-id><?supplied-pmid 21338678?><pub-id pub-id-type="pmid">21338678</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fletcher</surname><given-names>HA</given-names></name><name><surname>Snowden</surname><given-names>MA</given-names></name><name><surname>Landry</surname><given-names>B</given-names></name><name><surname>Rida</surname><given-names>W</given-names></name><name><surname>Satti</surname><given-names>I</given-names></name><name><surname>Harris</surname><given-names>SA</given-names></name><etal/></person-group>
<article-title>T-cell activation is an immune correlate of risk in BCG vaccinated infants</article-title>. <source>Nat Commun</source> (<year>2016</year>) <volume>7</volume>:<fpage>11290</fpage>.<pub-id pub-id-type="doi">10.1038/ncomms11290</pub-id><?supplied-pmid 27068708?><pub-id pub-id-type="pmid">27068708</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallis</surname><given-names>RS</given-names></name><name><surname>Kim</surname><given-names>P</given-names></name><name><surname>Cole</surname><given-names>S</given-names></name><name><surname>Hanna</surname><given-names>D</given-names></name><name><surname>Andrade</surname><given-names>BB</given-names></name><name><surname>Maeurer</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Tuberculosis biomarkers discovery: developments, needs, and challenges</article-title>. <source>Lancet Infect Dis</source> (<year>2013</year>) <volume>13</volume>(<issue>4</issue>):<fpage>362</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1016/S1473-3099(13)70034-3</pub-id><?supplied-pmid 23531389?><pub-id pub-id-type="pmid">23531389</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Blankley</surname><given-names>S</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>Bloom</surname><given-names>CI</given-names></name><name><surname>O&#x02019;Garra</surname><given-names>A</given-names></name></person-group>. <article-title>Systems approaches to studying the immune response in tuberculosis</article-title>. <source>Curr Opin Immunol</source> (<year>2013</year>) <volume>25</volume>(<issue>5</issue>):<fpage>579</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="doi">10.1016/j.coi.2013.08.003</pub-id><?supplied-pmid 24021227?><pub-id pub-id-type="pmid">24021227</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fletcher</surname><given-names>HA</given-names></name></person-group>. <article-title>Profiling the host immune response to tuberculosis vaccines</article-title>. <source>Vaccine</source> (<year>2015</year>) <volume>33</volume>(<issue>40</issue>):<fpage>5313</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2015.07.090</pub-id><?supplied-pmid 26241949?><pub-id pub-id-type="pmid">26241949</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Bloch</surname><given-names>SA</given-names></name><name><surname>Oni</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title>. <source>Nature</source> (<year>2010</year>) <volume>466</volume>(<issue>7309</issue>):<fpage>973</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/nature09247</pub-id><?supplied-pmid 20725040?><pub-id pub-id-type="pmid">20725040</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloom</surname><given-names>CI</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Rozakeas</surname><given-names>F</given-names></name><name><surname>Redford</surname><given-names>PS</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>(<issue>8</issue>):<fpage>e70630</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0070630</pub-id><?supplied-pmid 23940611?><pub-id pub-id-type="pmid">23940611</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maertzdorf</surname><given-names>J</given-names></name><name><surname>Repsilber</surname><given-names>D</given-names></name><name><surname>Parida</surname><given-names>SK</given-names></name><name><surname>Stanley</surname><given-names>K</given-names></name><name><surname>Roberts</surname><given-names>T</given-names></name><name><surname>Black</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Human gene expression profiles of susceptibility and resistance in tuberculosis</article-title>. <source>Genes Immun</source> (<year>2011</year>) <volume>12</volume>(<issue>1</issue>):<fpage>15</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1038/gene.2010.51</pub-id><?supplied-pmid 20861863?><pub-id pub-id-type="pmid">20861863</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zak</surname><given-names>DE</given-names></name><name><surname>Penn-Nicholson</surname><given-names>A</given-names></name><name><surname>Scriba</surname><given-names>TJ</given-names></name><name><surname>Thompson</surname><given-names>E</given-names></name><name><surname>Suliman</surname><given-names>S</given-names></name><name><surname>Amon</surname><given-names>LM</given-names></name><etal/></person-group>
<article-title>A blood RNA signature for tuberculosis disease risk: a prospective cohort study</article-title>. <source>Lancet</source> (<year>2016</year>) <volume>387</volume>(<issue>10035</issue>):<fpage>2312</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1016/S0140-6736(15)01316-1</pub-id><?supplied-pmid 27017310?><pub-id pub-id-type="pmid">27017310</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloom</surname><given-names>CI</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Wilkinson</surname><given-names>KA</given-names></name><name><surname>Oni</surname><given-names>T</given-names></name><name><surname>Rozakeas</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy</article-title>. <source>PLoS One</source> (<year>2012</year>) <volume>7</volume>(<issue>10</issue>):<fpage>e46191</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0046191</pub-id><?supplied-pmid 23056259?><pub-id pub-id-type="pmid">23056259</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Rouphael</surname><given-names>N</given-names></name><name><surname>Duraisingham</surname><given-names>S</given-names></name><name><surname>Romero-Steiner</surname><given-names>S</given-names></name><name><surname>Presnell</surname><given-names>S</given-names></name><name><surname>Davis</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Molecular signatures of antibody responses derived from a systems biology study of five human vaccines</article-title>. <source>Nat Immunol</source> (<year>2014</year>) <volume>15</volume>(<issue>2</issue>):<fpage>195</fpage>&#x02013;<lpage>204</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2789</pub-id><?supplied-pmid 24336226?><pub-id pub-id-type="pmid">24336226</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haralambieva</surname><given-names>IH</given-names></name><name><surname>Oberg</surname><given-names>AL</given-names></name><name><surname>Dhiman</surname><given-names>N</given-names></name><name><surname>Ovsyannikova</surname><given-names>IG</given-names></name><name><surname>Kennedy</surname><given-names>RB</given-names></name><name><surname>Grill</surname><given-names>DE</given-names></name><etal/></person-group>
<article-title>High-dimensional gene expression profiling studies in high and low responders to primary smallpox vaccination</article-title>. <source>J Infect Dis</source> (<year>2012</year>) <volume>206</volume>(<issue>10</issue>):<fpage>1512</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jis546</pub-id><?supplied-pmid 22949304?><pub-id pub-id-type="pmid">22949304</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haralambieva</surname><given-names>IH</given-names></name><name><surname>Oberg</surname><given-names>AL</given-names></name><name><surname>Ovsyannikova</surname><given-names>IG</given-names></name><name><surname>Kennedy</surname><given-names>RB</given-names></name><name><surname>Grill</surname><given-names>DE</given-names></name><name><surname>Middha</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Genome-wide characterization of transcriptional patterns in high and low antibody responders to rubella vaccination</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>(<issue>5</issue>):<fpage>e62149</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0062149</pub-id><?supplied-pmid 23658707?><pub-id pub-id-type="pmid">23658707</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henn</surname><given-names>AD</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Qiu</surname><given-names>X</given-names></name><name><surname>Ruda</surname><given-names>M</given-names></name><name><surname>Stover</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>High-resolution temporal response patterns to influenza vaccine reveal a distinct human plasma cell gene signature</article-title>. <source>Sci Rep</source> (<year>2013</year>) <volume>3</volume>:<fpage>2327</fpage>.<pub-id pub-id-type="doi">10.1038/srep02327</pub-id><?supplied-pmid 23900141?><pub-id pub-id-type="pmid">23900141</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obermoser</surname><given-names>G</given-names></name><name><surname>Presnell</surname><given-names>S</given-names></name><name><surname>Domico</surname><given-names>K</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Anguiano</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>38</volume>(<issue>4</issue>):<fpage>831</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2012.12.008</pub-id><?supplied-pmid 23601689?><pub-id pub-id-type="pmid">23601689</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakaya</surname><given-names>HI</given-names></name><name><surname>Wrammert</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>EK</given-names></name><name><surname>Racioppi</surname><given-names>L</given-names></name><name><surname>Marie-Kunze</surname><given-names>S</given-names></name><name><surname>Haining</surname><given-names>WN</given-names></name><etal/></person-group>
<article-title>Systems biology of vaccination for seasonal influenza in humans</article-title>. <source>Nat Immunol</source> (<year>2011</year>) <volume>12</volume>(<issue>8</issue>):<fpage>786</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2067</pub-id><?supplied-pmid 21743478?><pub-id pub-id-type="pmid">21743478</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Querec</surname><given-names>TD</given-names></name><name><surname>Akondy</surname><given-names>RS</given-names></name><name><surname>Lee</surname><given-names>EK</given-names></name><name><surname>Cao</surname><given-names>W</given-names></name><name><surname>Nakaya</surname><given-names>HI</given-names></name><name><surname>Teuwen</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans</article-title>. <source>Nat Immunol</source> (<year>2009</year>) <volume>10</volume>(<issue>1</issue>):<fpage>116</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1038/ni.1688</pub-id><?supplied-pmid 19029902?><pub-id pub-id-type="pmid">19029902</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zak</surname><given-names>DE</given-names></name><name><surname>Andersen-Nissen</surname><given-names>E</given-names></name><name><surname>Peterson</surname><given-names>ER</given-names></name><name><surname>Sato</surname><given-names>A</given-names></name><name><surname>Hamilton</surname><given-names>MK</given-names></name><name><surname>Borgerding</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Merck Ad5/HIV induces broad innate immune activation that predicts CD8<sup>+</sup> T-cell responses but is attenuated by preexisting Ad5 immunity</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2012</year>) <volume>109</volume>(<issue>50</issue>):<fpage>E3503</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1208972109</pub-id><pub-id pub-id-type="pmid">23151505</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaucher</surname><given-names>D</given-names></name><name><surname>Therrien</surname><given-names>R</given-names></name><name><surname>Kettaf</surname><given-names>N</given-names></name><name><surname>Angermann</surname><given-names>BR</given-names></name><name><surname>Boucher</surname><given-names>G</given-names></name><name><surname>Filali-Mouhim</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses</article-title>. <source>J Exp Med</source> (<year>2008</year>) <volume>205</volume>(<issue>13</issue>):<fpage>3119</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20082292</pub-id><?supplied-pmid 19047440?><pub-id pub-id-type="pmid">19047440</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazmin</surname><given-names>D</given-names></name><name><surname>Nakaya</surname><given-names>HI</given-names></name><name><surname>Lee</surname><given-names>EK</given-names></name><name><surname>Johnson</surname><given-names>MJ</given-names></name><name><surname>van der Most</surname><given-names>R</given-names></name><name><surname>van den Berg</surname><given-names>RA</given-names></name><etal/></person-group>
<article-title>Systems analysis of protective immune responses to RTS,S malaria vaccination in humans</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2017</year>) <volume>114</volume>(<issue>9</issue>):<fpage>2425</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1621489114</pub-id><?supplied-pmid 28193898?><pub-id pub-id-type="pmid">28193898</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Berg</surname><given-names>RA</given-names></name><name><surname>Coccia</surname><given-names>M</given-names></name><name><surname>Ballou</surname><given-names>WR</given-names></name><name><surname>Kester</surname><given-names>KE</given-names></name><name><surname>Ockenhouse</surname><given-names>CF</given-names></name><name><surname>Vekemans</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Predicting RTS,S vaccine-mediated protection from transcriptomes in a malaria-challenge clinical trial</article-title>. <source>Front Immunol</source> (<year>2017</year>) <volume>8</volume>:<fpage>557</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2017.00557</pub-id><?supplied-pmid 28588574?><pub-id pub-id-type="pmid">28588574</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gar&#x000e7;on</surname><given-names>N</given-names></name><name><surname>Van Mechelen</surname><given-names>M</given-names></name></person-group>. <article-title>Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems</article-title>. <source>Expert Rev Vaccines</source> (<year>2011</year>) <volume>10</volume>(<issue>4</issue>):<fpage>471</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1586/erv.11.29</pub-id><?supplied-pmid 21506645?><pub-id pub-id-type="pmid">21506645</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vahey</surname><given-names>MT</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Kester</surname><given-names>KE</given-names></name><name><surname>Cummings</surname><given-names>J</given-names></name><name><surname>Heppner</surname><given-names>DG</given-names><suffix>Jr</suffix></name><name><surname>Nau</surname><given-names>ME</given-names></name><etal/></person-group>
<article-title>Expression of genes associated with immunoproteasome processing of major histocompatibility complex peptides is indicative of protection with adjuvanted RTS,S malaria vaccine</article-title>. <source>J Infect Dis</source> (<year>2010</year>) <volume>201</volume>(<issue>4</issue>):<fpage>580</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1086/650310</pub-id><?supplied-pmid 20078211?><pub-id pub-id-type="pmid">20078211</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourguignon</surname><given-names>P</given-names></name><name><surname>Cl&#x000e9;ment</surname><given-names>F</given-names></name><name><surname>Renaud</surname><given-names>F</given-names></name><name><surname>Le Bras</surname><given-names>V</given-names></name><name><surname>Koutsoukos</surname><given-names>M</given-names></name><name><surname>Burny</surname><given-names>W</given-names></name><etal/></person-group>
<article-title>Processing of blood samples influences PBMC viability and outcome of cell-mediated immune responses in antiretroviral therapy-naive HIV-1-infected patients</article-title>. <source>J Immunol Methods</source> (<year>2014</year>) <volume>414</volume>:<fpage>1</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="doi">10.1016/j.jim.2014.09.001</pub-id><pub-id pub-id-type="pmid">25224748</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waldrop</surname><given-names>SL</given-names></name><name><surname>Davis</surname><given-names>KA</given-names></name><name><surname>Maino</surname><given-names>VC</given-names></name><name><surname>Picker</surname><given-names>LJ</given-names></name></person-group>. <article-title>Normal human CD4<sup>+</sup> memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis</article-title>. <source>J Immunol</source> (<year>1998</year>) <volume>161</volume>(<issue>10</issue>):<fpage>5284</fpage>&#x02013;<lpage>95</lpage>.<?supplied-pmid 9820501?><pub-id pub-id-type="pmid">9820501</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Irizarry</surname><given-names>RA</given-names></name><name><surname>Gentleman</surname><given-names>R</given-names></name><name><surname>Martinez-Murillo</surname><given-names>F</given-names></name><name><surname>Spencer</surname><given-names>F</given-names></name></person-group>
<article-title>A model-based background adjustment for oligonucleotide expression arrays</article-title>. <source>J Am Stat Assoc</source> (<year>2004</year>) <volume>99</volume>(<issue>468</issue>):<fpage>909</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="doi">10.1198/016214504000000683</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bolstad</surname><given-names>BM</given-names></name></person-group>
<source>Low Level Analysis of High-density Oligonucleotide Array Data: Background, Normalization and Summarization</source>. <publisher-loc>Berkeley, USA</publisher-loc>: <publisher-name>University of California</publisher-name> (<year>2004</year>).</mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bolstad</surname><given-names>BM</given-names></name><name><surname>Collin</surname><given-names>F</given-names></name><name><surname>Brettschneider</surname><given-names>J</given-names></name><name><surname>Simpson</surname><given-names>K</given-names></name><name><surname>Cope</surname><given-names>L</given-names></name><name><surname>Irizarry</surname><given-names>RA</given-names></name><etal/></person-group>
<article-title>Quality assessment of affymetrix GeneChip data</article-title>. In: <person-group person-group-type="editor"><name><surname>Gentleman</surname><given-names>R</given-names></name><name><surname>Carey</surname><given-names>V</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Irizarry</surname><given-names>R</given-names></name><name><surname>Dudoit</surname><given-names>S</given-names></name></person-group>, editors. <source>Bioinformatics and Computational Biology Solutions Using R and Bioconductor</source>. <publisher-loc>New York, USA</publisher-loc>: <publisher-name>Springer</publisher-name> (<year>2005</year>). p. <fpage>33</fpage>&#x02013;<lpage>47</lpage>.</mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brettschneider</surname><given-names>J</given-names></name><name><surname>Collin</surname><given-names>F</given-names></name><name><surname>Bolstad</surname><given-names>BM</given-names></name><name><surname>Speed</surname><given-names>TP</given-names></name></person-group>
<article-title>Quality assessment for short oligonucleotide microarray data technometrics</article-title>. <source>Technometrics</source> (<year>2008</year>) <volume>50</volume>(<issue>3</issue>):<fpage>241</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1198/004017008000000334</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phipson</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Majewski</surname><given-names>IJ</given-names></name><name><surname>Alexander</surname><given-names>WS</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group>. <article-title>Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression</article-title>. <source>Ann Appl Stat</source> (<year>2016</year>) <volume>10</volume>(<issue>2</issue>):<fpage>946</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1214/16-AOAS920</pub-id><?supplied-pmid 28367255?><pub-id pub-id-type="pmid">28367255</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>ME</given-names></name><name><surname>Phipson</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Law</surname><given-names>CW</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><etal/></person-group>
<article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>. <source>Nucleic Acids Res</source> (<year>2015</year>) <volume>43</volume>(<issue>7</issue>):<fpage>e47</fpage>.<pub-id pub-id-type="doi">10.1093/nar/gkv007</pub-id><?supplied-pmid 25605792?><pub-id pub-id-type="pmid">25605792</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Ritchie</surname><given-names>ME</given-names></name><name><surname>Thorne</surname><given-names>N</given-names></name><name><surname>Wettenhall</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name></person-group>
<article-title>Statistics for differential expression</article-title>. <edition>2nd ed</edition>
<source>limma: Linear Models for Microarray and RNA-seq Data User&#x02019;s Guide</source> (<year>2016</year>). p. <fpage>60</fpage>&#x02013;<lpage>8</lpage>. Available from: <uri xlink:type="simple" xlink:href="http://www.bioconductor.org">www.bioconductor.org</uri></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiner</surname><given-names>J</given-names><suffix>III</suffix></name><name><surname>Domaszewska</surname><given-names>T</given-names></name></person-group>
<article-title>tmod: an R package for general and multivariate enrichment analysis</article-title>. <source>PeerJ Preprints</source> (<year>2016</year>) <volume>4</volume>:<fpage>e2420v1</fpage><pub-id pub-id-type="doi">10.7287/peerj.preprints.2420v1</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Efron</surname><given-names>B</given-names></name><name><surname>Tibshirani</surname><given-names>RJ</given-names></name></person-group>
<source>An Introduction to the Bootstrap</source>. <publisher-loc>Boca Raton, FL</publisher-loc>: <publisher-name>CRC Press</publisher-name> (<year>1994</year>).</mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kester</surname><given-names>KE</given-names></name><name><surname>Cummings</surname><given-names>JF</given-names></name><name><surname>Ofori-Anyinam</surname><given-names>O</given-names></name><name><surname>Ockenhouse</surname><given-names>CF</given-names></name><name><surname>Krzych</surname><given-names>U</given-names></name><name><surname>Moris</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection</article-title>. <source>J Infect Dis</source> (<year>2009</year>) <volume>200</volume>(<issue>3</issue>):<fpage>337</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="doi">10.1086/600120</pub-id><?supplied-pmid 19569965?><pub-id pub-id-type="pmid">19569965</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Nakaya</surname><given-names>HI</given-names></name><name><surname>Kazmin</surname><given-names>DA</given-names></name><name><surname>Oh</surname><given-names>JZ</given-names></name><name><surname>Pulendran</surname><given-names>B</given-names></name></person-group>. <article-title>Systems biological approaches to measure and understand vaccine immunity in humans</article-title>. <source>Semin Immunol</source> (<year>2013</year>) <volume>25</volume>(<issue>3</issue>):<fpage>209</fpage>&#x02013;<lpage>18</lpage>.<pub-id pub-id-type="doi">10.1016/j.smim.2013.05.003</pub-id><?supplied-pmid 23796714?><pub-id pub-id-type="pmid">23796714</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Didierlaurent</surname><given-names>AM</given-names></name><name><surname>Collignon</surname><given-names>C</given-names></name><name><surname>Bourguignon</surname><given-names>P</given-names></name><name><surname>Wouters</surname><given-names>S</given-names></name><name><surname>Fierens</surname><given-names>K</given-names></name><name><surname>Fochesato</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>193</volume>(<issue>4</issue>):<fpage>1920</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1400948</pub-id><?supplied-pmid 25024381?><pub-id pub-id-type="pmid">25024381</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coccia</surname><given-names>M</given-names></name><name><surname>Collignon</surname><given-names>C</given-names></name><name><surname>Herv&#x000e9;</surname><given-names>C</given-names></name><name><surname>Chalon</surname><given-names>A</given-names></name><name><surname>Welsby</surname><given-names>I</given-names></name><name><surname>Detienne</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFN&#x003b3; response promoting vaccine immunogenicity</article-title>. <source>NPJ Vaccines</source> (<year>2017</year>) <volume>2</volume>(<issue>1</issue>):<fpage>25</fpage><pub-id pub-id-type="doi">10.1038/s41541-017-0027-3</pub-id><pub-id pub-id-type="pmid">29263880</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>LF</given-names></name><name><surname>Han</surname><given-names>A</given-names></name><name><surname>McGuire</surname><given-names>HM</given-names></name><name><surname>Furman</surname><given-names>D</given-names></name><name><surname>Newell</surname><given-names>EW</given-names></name><name><surname>Davis</surname><given-names>MM</given-names></name></person-group>. <article-title>The promised land of human immunology</article-title>. <source>Cold Spring Harb Symp Quant Biol</source> (<year>2013</year>) <volume>78</volume>:<fpage>203</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="doi">10.1101/sqb.2013.78.022905</pub-id><?supplied-pmid 24638855?><pub-id pub-id-type="pmid">24638855</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moris</surname><given-names>P</given-names></name><name><surname>Jongert</surname><given-names>E</given-names></name><name><surname>van der Most</surname><given-names>RG</given-names></name></person-group>
<article-title>Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine</article-title>. <source>Hum Vaccin Immunother</source> (<year>2017</year>) <volume>14</volume>(<issue>1</issue>):<fpage>17</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="doi">10.1080/21645515.2017.1381809</pub-id><pub-id pub-id-type="pmid">28934066</pub-id></mixed-citation></ref></